Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura.

Abstract excerpt

INTRODUCTION: Hereditary thrombotic thrombocytopenic purpura (hTTP) is caused by deficiency of plasma ADAMTS13 activity, resulting from ADAMTS13 mutations. ADAMTS13 cleaves ultra large von Willebrand factor (VWF), thus reducing its multimer sizes. Hereditary deficiency of plasma ADAMTS13 activity leads to the formation of excessive platelet-VWF aggregates in small arterioles and capillaries, resulting in hTTP....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to ADAMTS13 Protein
• Share to Disease Management
• Share to Factor VIII